Titan Pharmaceuticals Inc (TTNP) — Cash Flow Quality Index
Titan Pharmaceuticals Inc (TTNP) has a Cash Flow Quality Index of 1.13x as of June 2016. Operating cash flow of $13.51 Million exceeds net income of $11.93 Million, indicating high earnings quality where cash backs reported profits. Explore Titan Pharmaceuticals Inc operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Titan Pharmaceuticals Inc Cash Flow Quality Index (1997–2016)
Historical Cash Flow Quality Index for Titan Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check TTNP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Titan Pharmaceuticals Inc (1997–2016)
Year-by-year earnings quality comparison for Titan Pharmaceuticals Inc. For live market cap and the full company financial profile, see Titan Pharmaceuticals Inc (TTNP) market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.23x | $6.29 Million | $5.13 Million | ▲ +221.5% |
| 2013 | -1.01x | $-9.80 Million | $9.71 Million | ▼ -108.5% |
| 1997 | 11.83x | $7.10 Million | $600.00K | — |